Copper
Copper is an essential transition metal with broad biological and medical relevance.
Copper is an essential transition metal with broad biological and medical relevance. In living systems, copper exists in tightly regulated ionic forms, most notably Cu(I) and Cu(II), because unbound copper can participate in redox chemistry that influences oxidative stress, reactive oxygen species formation, and cellular signaling. This tight control is important for maintaining normal mitochondrial function, enzyme activity, and metal homeostasis, while copper imbalance can contribute to pathological states such as Wilson's disease and can also be exploited therapeutically in cancer biology.
In biomedical research, copper is increasingly studied not only as a trace element and diagnostic analyte, but also as a mechanistic driver of copper-dependent cell death, including cuproptosis. Recent work has focused on copper delivery, intracellular copper release, and copper-triggered mitochondrial proteotoxicity, particularly in tumor cells and the tumor microenvironment. Copper has also been combined with materials-based platforms, prodrugs, and photothermal or hydrogel systems to enhance targeted therapy, immune reprogramming, and controlled copper release in diseases such as cancer and metabolic liver disease.
Where the papers sit
24 papers from the last 6 months study copper directly · updated from PubMed 10 Oct 2026
Study type 1 clinical trial · 1 observational · 3 human data · 18 preclinical · 1 unclassified
Themes one subject · 1 new direction
Those 24 are all about one subject.
-
Metal-Linked Biology and Materials
Metal-linked biology and materials span copper-driven redox effects, amyloid aggregation, cuproptosis, infection control, tissue repair, and engineered composites. Biomedical studies use chelation, nanoparticles, hydrogels, nanoclusters, and immunotherapy to alter metal handling or exploit metal toxicity. Other work addresses material properties and responsive scaffolds rather than a shared disease mechanism. No single therapeutic direction dominates, but copper-mediated oxidative stress and metal-enabled intervention recur across the set.
Copper, rather than zinc, can govern chelator-induced axon-regeneration effects
The optic nerve injury model studied with TPEN and the Cu(I)-selective chelator PSP-2 found that copper chelation, not zinc chelation, likely stimulates axon regeneration, while TPEN sequesters attomolar-buffered cellular Cu(I) through an oxygen-dependent redox-trapping mechanism 42615641Aug. This assigns copper a previously unrepresented role as the biologically relevant determinant of a regeneration phenotype and identifies TPEN's presumed zinc-specific use as a confounded interpretation, shifting experimental attention toward copper-selective tools and copper regulation in neural repair.
Papers
The 24 papers from the last 6 months that study copper directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Metal-Linked Biology and Materials (24)
- Restoring brain functions in the Mo-blo mouse model of Menkes disease with copper nanoclusters. Science advances · 30 Sept 2026 PMID 42814820
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
- Prediction of the properties of sintered copper-graphite composites using response surface methodology. PloS one · 11 Sept 2026 PMID 42726785
- An Inhalable Hybrid Nitric Oxide Nanogenerator for Lung Adenocarcinoma Treatment via Bioorthogonal-Activated Gas-Immunotherapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714559
- Metal-Ion-Mediated Amyloid- β Aggregation in Alzheimer's Disease: A Mathematical Model of Chelation and Inhibitory Therapies. Bulletin of mathematical biology · 21 Aug 2026 PMID 42624961
- TPEN, a Well-Known Zinc Chelator, Sequesters Attomolar-Buffered Cellular Cu(I) Through an Oxygen-Dependent Mechanism. ACS chemical neuroscience · 19 Aug 2026 PMID 42615641
- Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer. ACS nano · 18 Aug 2026 PMID 42611215
- Solvent-Directed Assembly and Rheological Dynamics of Multistimuli-Responsive Mg(II) and Cu(II) Metallosupramolecular Flexible Nanoscaffolds for Biological Applications. The journal of physical chemistry. B · 13 Aug 2026 PMID 42593139
- Chirality-dependent antibacterial activity of copper-cysteine nanoparticles enables functional silk sutures for enhanced wound healing. Biomaterials science · 13 Aug 2026 PMID 42592816
- Multi-omics mechanistic studies for curcumin-mediated intracellular copper release to alleviate MAFLD. Naunyn-Schmiedeberg's archives of pharmacology · 12 Aug 2026 PMID 42584672
- Ultrasound-responsive metastable copper/zinc-polyphenol framework for targeted anti-infection of diabetic wounds. Journal of controlled release : official journal of the Controlled Release Society · 10 Aug 2026 PMID 42575213
- Metal Ion-Triggered Collapsed Hydrogels as Materials for Bacterial Population Control. ACS applied bio materials · 10 Aug 2026 PMID 42574693
- Silver and Copper Nanoparticles as Non-Antibiotic Therapy for Postpartum Endometritis in Dairy Cows. Veterinary medicine and science · 5 Aug 2026 PMID 42555560
- A copper nanoplatform with irreversible electroporation induces cuproptosis via lipid reprogramming and remodels tumor immunity in pancreatic cancer. Journal of controlled release : official journal of the Controlled Release Society · 26 Jul 2026 PMID 42503313
- An injectable thiolated alginate/oxidized dextran hydrogel with curcumin-copper nanoparticles for corneal neovascularization after alkali burn. Carbohydrate polymers · 23 Jul 2026 PMID 42493130
- Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. Cell reports. Medicine · 22 Jul 2026 PMID 42486098
- Design of an activatable unimolecular multicargo prodrug to deliver diethyldithiocarbamate and copper for targeted ovarian cancer therapy. Chemical communications (Cambridge, England) · 21 Jul 2026 PMID 42478879
- Plasmonic trimer nanoarrays with probe-trapping sites for SERS detection of urinary copper in Wilson's disease. The Analyst · 10 Jul 2026 PMID 42429542
- Electric-Field-Driven Ferredoxin 1-Independent Cuproptosis Induction Overcomes Therapy-Induced Resistance in Glioblastoma. ACS nano · 7 Jul 2026 PMID 42411583
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- A Self-Monitoring Single-Atom Copper Nanocapsule for Cascade-Responsive Tumor Cuproptosis Therapy. Angewandte Chemie (International ed. in English) · 6 Jul 2026 PMID 42405495
- Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia · 2 Jul 2026 PMID 42392517
- Photothermal Pulse Output-Nanomachines for Enhanced Cuproptosis in Tumor Cells. ACS applied bio materials · 30 Jun 2026 PMID 42378513
- In vitro effects of pH variation and immune-induced copper accumulation on the antibacterial and cytotoxic activity of levofloxacin during Streptococcus pneumoniae infection. Bioorganic chemistry · 13 May 2026 PMID 42127742
By study type
Clinical trials (1)
- Silver and Copper Nanoparticles as Non-Antibiotic Therapy for Postpartum Endometritis in Dairy Cows. Veterinary medicine and science · 5 Aug 2026 PMID 42555560
Observational studies and case reports (1)
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
Human data, design not indexed (3)
- Metal-Ion-Mediated Amyloid- β Aggregation in Alzheimer's Disease: A Mathematical Model of Chelation and Inhibitory Therapies. Bulletin of mathematical biology · 21 Aug 2026 PMID 42624961
- Plasmonic trimer nanoarrays with probe-trapping sites for SERS detection of urinary copper in Wilson's disease. The Analyst · 10 Jul 2026 PMID 42429542
- Photothermal Pulse Output-Nanomachines for Enhanced Cuproptosis in Tumor Cells. ACS applied bio materials · 30 Jun 2026 PMID 42378513
Preclinical: animal, cell and lab studies (18)
- Restoring brain functions in the Mo-blo mouse model of Menkes disease with copper nanoclusters. Science advances · 30 Sept 2026 PMID 42814820
- Prediction of the properties of sintered copper-graphite composites using response surface methodology. PloS one · 11 Sept 2026 PMID 42726785
- An Inhalable Hybrid Nitric Oxide Nanogenerator for Lung Adenocarcinoma Treatment via Bioorthogonal-Activated Gas-Immunotherapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714559
- TPEN, a Well-Known Zinc Chelator, Sequesters Attomolar-Buffered Cellular Cu(I) Through an Oxygen-Dependent Mechanism. ACS chemical neuroscience · 19 Aug 2026 PMID 42615641
- Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer. ACS nano · 18 Aug 2026 PMID 42611215
- Solvent-Directed Assembly and Rheological Dynamics of Multistimuli-Responsive Mg(II) and Cu(II) Metallosupramolecular Flexible Nanoscaffolds for Biological Applications. The journal of physical chemistry. B · 13 Aug 2026 PMID 42593139
- Chirality-dependent antibacterial activity of copper-cysteine nanoparticles enables functional silk sutures for enhanced wound healing. Biomaterials science · 13 Aug 2026 PMID 42592816
- Ultrasound-responsive metastable copper/zinc-polyphenol framework for targeted anti-infection of diabetic wounds. Journal of controlled release : official journal of the Controlled Release Society · 10 Aug 2026 PMID 42575213
- Metal Ion-Triggered Collapsed Hydrogels as Materials for Bacterial Population Control. ACS applied bio materials · 10 Aug 2026 PMID 42574693
- A copper nanoplatform with irreversible electroporation induces cuproptosis via lipid reprogramming and remodels tumor immunity in pancreatic cancer. Journal of controlled release : official journal of the Controlled Release Society · 26 Jul 2026 PMID 42503313
- An injectable thiolated alginate/oxidized dextran hydrogel with curcumin-copper nanoparticles for corneal neovascularization after alkali burn. Carbohydrate polymers · 23 Jul 2026 PMID 42493130
- Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. Cell reports. Medicine · 22 Jul 2026 PMID 42486098
- Design of an activatable unimolecular multicargo prodrug to deliver diethyldithiocarbamate and copper for targeted ovarian cancer therapy. Chemical communications (Cambridge, England) · 21 Jul 2026 PMID 42478879
- Electric-Field-Driven Ferredoxin 1-Independent Cuproptosis Induction Overcomes Therapy-Induced Resistance in Glioblastoma. ACS nano · 7 Jul 2026 PMID 42411583
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- A Self-Monitoring Single-Atom Copper Nanocapsule for Cascade-Responsive Tumor Cuproptosis Therapy. Angewandte Chemie (International ed. in English) · 6 Jul 2026 PMID 42405495
- Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia · 2 Jul 2026 PMID 42392517
- In vitro effects of pH variation and immune-induced copper accumulation on the antibacterial and cytotoxic activity of levofloxacin during Streptococcus pneumoniae infection. Bioorganic chemistry · 13 May 2026 PMID 42127742
Unclassified: not yet indexed with MeSH (1)
- Multi-omics mechanistic studies for curcumin-mediated intracellular copper release to alleviate MAFLD. Naunyn-Schmiedeberg's archives of pharmacology · 12 Aug 2026 PMID 42584672
Written from 24 PubMed abstracts, each one listed by PMID above. Published: 2026-08-15. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.